In patients with head and neck cancer, a strategy to reduce the radiation dose to dysphagia-and aspiration-related structures improved swallowing and other functional outcomes compared with standard intensity-modulated radiotherapy (IMRT), according to results from the phase III DARS trial.

Adding docetaxel to radiation therapy improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomised trial showed.

Radiotherapy is one of the main treatment modalities in cancer management, often used in combination with other treatments, such as surgery or chemotherapy. Approximately 40% of cancer cures are attributed to radiotherapy. Read the full report now